JW Lifescience Corporation (234080.KS) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 198.49B |
| Enterprise Value | 240.69B |
| P/E Ratio | 5.81 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 0.69 |
| Price/Book Ratio | 0.79 |
| Enterprise/Revenue | 0.83 |
| Enterprise/EBITDA | 3.29 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 257.83B |
| Revenue/Share | 15,482.7 |
| Gross Profit | 69.77B |
| EBITDA | 51.41B |
| Net Income | 28.61B |
| Diluted EPS | 1,847.38 |
Balance Sheet
| Total Cash | 12.2B |
| Total Cash/Share | 770.54 |
| Total Debt | 42.25B |
| Total Debt/Equity | 0.19 |
| Current Ratio | 1.09 |
| Book Value Per Share | 13,814.24 |
Price History
| 52-Week Change | -9.35 |
| 52-Week High | 15,580 |
| 52-Week Low | 10,600 |
| Moving Average 50 Days | 12,112 |
| Moving Average 200 Days | 12,907.25 |
Statistics
| Average Volume | 40,848 |
| Shares Outstanding | 15.48M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 550 |
| Trailing Annual Dividend Yield | 5.02 |
| Payout Ratio | 0.27 |
| Last Split Factor | 2:1 |
| Last Split Date | May 15, 2018 |
AD
